Injection of the 5-HT2C receptor agonist Ro60-0175 into the ventral tegmental area reduces cocaine-induced locomotor activity and cocaine self-administration.
about
Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbensDual dopamine/serotonin releasers: potential treatment agents for stimulant addictionQuantitative analysis of 5HT(2C) receptor RNA editing patterns in psychiatric disordersBalance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugsRegion-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptorsPharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction.Role of serotonin 5-HT2A and 5-HT2C receptors on brain stimulation reward and the reward-facilitating effect of cocaine.The contribution of brain reward circuits to the obesity epidemicConvergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models.The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens.Serotonin (5-HT) precursor loading with 5-hydroxy-l-tryptophan (5-HTP) reduces locomotor activation produced by (+)-amphetamine in the rat.Differential regulation of the mesoaccumbens dopamine circuit by serotonin2C receptors in the ventral tegmental area and the nucleus accumbens: an in vivo microdialysis study with cocaine.The 5-HT2C receptor agonist Ro60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues.Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model.Fine-tuning serotonin2c receptor function in the brain: molecular and functional implicationsCocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice.Pharmacologic rescue of motivational deficit in an animal model of the negative symptoms of schizophreniaAttenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys by direct and indirect activation of 5-HT2C receptors.Role of 5-HT₂C receptors in effects of monoamine releasers on intracranial self-stimulation in ratsHypothesis-driven medication discovery for the treatment of psychostimulant addictionIndividual differences in the sensitivity to serotonergic drugs: a pharmacobehavioural approach using rats selected on the basis of their response to novelty.Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology.Serotonin2C receptors and drug addiction: focus on cocaine.The role of serotonin in memory: interactions with neurotransmitters and downstream signaling.Serotonin's Complex Role in Alcoholism: Implications for Treatment and Future Research.A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment.A systematic investigation of the differential roles for ventral tegmentum serotonin 1- and 2-type receptors on food intake in the rat.Serotonin2C receptors in the nucleus accumbens are involved in enhanced alcohol-drinking behavior.Blockade of nucleus accumbens 5-HT2A and 5-HT2C receptors prevents the expression of cocaine-induced behavioral and neurochemical sensitization in rats.Stimulation of medial prefrontal cortex serotonin 2C (5-HT(2C)) receptors attenuates cocaine-seeking behavior.Selective serotonin receptor stimulation of the medial nucleus accumbens differentially affects appetitive motivation for food on a progressive ratio schedule of reinforcement.Lorcaserin Suppresses Oxycodone Self-Administration and Relapse Vulnerability in Rats.Effects of lorcaserin (Belviq®) on nicotine- and food-maintained responding in non-human primates.Interactions between metabolic, reward and cognitive processes in appetite control: Implications for novel weight management therapies.Inhibition of cocaine and 3,4-methylenedioxypyrovalerone (MDPV) self-administration by lorcaserin is mediated by 5-HT2C receptors in rats.The 5-HT2C receptor agonist meta-chlorophenylpiperazine (mCPP) reduces palatable food consumption and BOLD fMRI responses to food images in healthy female volunteers.The behavioral pharmacology and therapeutic potential of lorcaserin for substance use disorders.Evidence for a role of 5-HT2C receptors in the motor aspects of performance, but not the efficacy of food reinforcers, in a progressive ratio schedule.Critical involvement of 5-HT2C receptor function in amphetamine-induced 50-kHz ultrasonic vocalizations in rats.
P2860
Q24596784-57AE158A-9A83-4F17-960E-C7C061E4729EQ24641896-67AF7299-1121-407C-AC7F-FDE16404FF8FQ27014825-AE60F1D5-4E0A-4242-8904-FB970D622913Q28274119-A47501A7-F25E-47D2-B7CA-7EA1FCC3E3DEQ28570213-74C2F008-FE59-4C9C-8604-9EC3E7A8627AQ30493133-5FA9574B-F66E-4F5C-8584-C7A9E07712B6Q33874819-005E462B-A590-4937-9712-20D8F639FC5AQ34122658-FFF65D87-9229-485D-AA08-06656149A8F3Q34317475-A2DE6C78-8431-4970-92C3-8545C10E346DQ34407185-1C8BE639-E17B-40E7-96F4-5A43A828FC62Q34546304-BCE548AC-5999-45A7-9D84-329B3AB2E884Q34605239-30EB77B5-547D-4EEA-B378-F4F53497DFF4Q34618432-33B9AD07-3271-4B1A-AD5B-2A9940DD3BF2Q34655896-F155BD2A-3782-4490-9D81-358F2414F268Q34971199-B394DC83-9B0D-46C7-8381-4DB5414DE1D9Q35072763-EF7BD18D-6CD4-42CA-8395-975027023985Q35157705-C122358F-B3D8-499C-A4B9-B73FB9D12413Q35207454-ACE66C39-0B6C-43FE-A959-57C08576CE51Q35889437-C3590AB3-C5CA-4E0C-B3DD-B247DE3342B0Q35952202-490CAC23-67BA-4AD3-9891-B255C9808DA3Q37183687-AC06D9F8-CD63-49D5-A0A2-A5FEC8DD7334Q37265383-21AA4408-9C5E-4A95-99B2-8E1E939F44AFQ38101499-ACAB8A5E-AEEE-4DBA-B72B-32FDF0905198Q38113111-8E0ED75E-DCAC-495B-ADE3-383E9A0E76B9Q38178842-ACA1B68C-F599-405A-B575-A55CFA76C8BCQ38830577-EF309F61-0B78-41D3-8C4B-90AABCEA66F1Q39164871-B7F63A23-C5C7-46F9-A7A2-77115C1F9D7BQ39587382-D1575273-5F91-4038-93F5-131148184DAFQ41458899-071A047A-E8DC-4BFC-B307-CD97AD694886Q41876191-FCBF0440-D9E8-4094-89D7-F8622D453E19Q42034255-F7508729-4756-4513-AC10-1EF84E5164C1Q42633021-035D65D5-4314-46FD-ACA2-88A636AE734BQ45051146-3AC1D259-189B-4124-BA35-67D1A31C2C8AQ46282660-3FEA512D-389B-4BDA-9F9A-1B056EEE24DCQ47102484-B5B83D26-DC27-4681-8C5D-8EAE221937D6Q47348330-CA5DC326-B044-46A1-980A-269860DF12DAQ47595946-FE4BFA0D-456F-4FAA-85FE-00A426C4F0ECQ47677518-F165DDD4-B43D-4A7D-863D-E93F83B6D0F3Q47738255-F75C4383-17E4-42A0-8478-AA4337683702Q47786557-478E6F13-00BD-49F6-B0C2-A3FCD3414EBF
P2860
Injection of the 5-HT2C receptor agonist Ro60-0175 into the ventral tegmental area reduces cocaine-induced locomotor activity and cocaine self-administration.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Injection of the 5-HT2C recept ...... d cocaine self-administration.
@en
Injection of the 5-HT2C recept ...... d cocaine self-administration.
@nl
type
label
Injection of the 5-HT2C recept ...... d cocaine self-administration.
@en
Injection of the 5-HT2C recept ...... d cocaine self-administration.
@nl
prefLabel
Injection of the 5-HT2C recept ...... d cocaine self-administration.
@en
Injection of the 5-HT2C recept ...... d cocaine self-administration.
@nl
P2093
P2860
P356
P1476
Injection of the 5-HT2C recept ...... d cocaine self-administration.
@en
P2093
Araba F Chintoh
Guy A Higgins
Judy Sinyard
Paul J Fletcher
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300319
P407
P577
2004-02-01T00:00:00Z
P6179
1041631260